RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 100-110
  • FDA approves 'rescue pen' aimed at curbing painkiller deaths

    Federal officials said Thursday they hoped a new "rescue pen" would help reduce the death toll from overdoses involving prescription painkillers. The Food and Drug Administration approved the sale, by prescription, of the prefilled auto-injector of...
  • The Kid's Doctor: Measles outbreak points again to the importance of vaccines

    With all of the news about the measles (rubeola) in California (51 cases) and New York (25 cases), all pediatricians are on the alert for any measles cases in our areas. I've written many times about the importance of vaccines, but this latest outbreak of...
  • Antidepressants & self-harm: For those under 24, initial dose matters

    Antidepressants & self-harm: For those under 24, initial dose matters
    About a decade after the Food and Drug Administration first warned that antidepressant medications increase the risk of suicidal thoughts and behaviors in children, new research has found that kids and young adults starting on high doses of...
  • When it comes to primary care, there's no place like a medical home

    Joe McDonald, 70, of Fairfax, Va., really likes his primary-care doctor. And it's no wonder. The retired finance manager can get same-day appointments at the Fairfax Family Practice, e-mail his physician or drop by the practice's walk-in clinic, even on...
  • Unless they persist, heart palpitations are usually benign

    Have you ever experienced the sensation that your heart has skipped a beat or suddenly started to race or even pound? Those sensations are known as palpitations. While frightening, they're not usually a sign of something serious. "Palpitations are most...
  • Ackman warns Allergan on offer

    Activist investor Bill Ackman warned Botox maker Allergan Inc. on Monday that it would be unwise to court potential buyers as an alternative to the offer that he and Valeant Pharmaceuticals International Inc. have made for the company. Last month,...
  • Free samples of prescription drugs are costly to patients, study says

    Free samples of prescription drugs are costly to patients, study says
    Free samples of prescription drugs may seem like a great deal for patients. But even when doctors think they’re doing patients a favor by handing out the freebies, the real beneficiaries are the drug manufacturers, according to new research in the...
  • Irish firm to buy fast-growing MS-drug maker Questcor for $5.6 billion

    Irish pharmaceutical company Mallinckrodt will pay $5.6 billion in cash and stock for Anaheim-based Questcor Pharmaceuticals Inc., a fast-growing bio-pharmaceutical firm that specializes in treating multiple sclerosis, the companies announced Monday....
  • Ackman, Valeant partnering in bid to acquire Botox maker Allergan

    Activist investor Bill Ackman is partnering with Valeant Pharmaceuticals in an attempt to buy Orange County pharmaceutical company Allergan Inc., which sells the popular wrinkle treatment Botox. Ackman’s Pershing Square Capital Management said...
  • Novartis, GSK announce multibillion-dollar overhaul of drug businesses

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses
    Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...
  • Convenience and savings seldom mix: What not to buy at drugstores

    Drugstores offer a convenient way to shop for a variety of items, especially if you live in a big city that has one on practically every corner. However, convenience doesn't always mean savings, says Howard Schaffer, a deal expert and vice president of...